Skip to main content

Outset Medical, Inc.

corporate_fare Company Profile

Outset Medical, Inc.

OM·NASDAQ·Industrial Applications And Services·CIK 0001484612

Outset is a medical technology company that has developed the Tablo® Hemodialysis System (Tablo), a technology designed to improve dialysis outcomes while reducing cost and complexity. Tablo is a single enterprise solution intended for use across various care settings, enabling dialysis to be delivered in hospitals, clinics, or at home. The U.S. Food and Drug Administration (FDA) has cleared Tablo for these uses. The system operates using only an electrical outlet and tap water, eliminating the need for the extensive infrastructure typically required by traditional dialysis machines. Tablo integrates water purification and on-demand dialysate production within a single 35-inch compact console. It utilizes cloud technology, allowing providers to remotely monitor devices and treatments, conduct patient and population analytics, and automate clinical recordkeeping. The system features a simple-to-use touchscreen interface and two-way wireless data transmission, supported by a proprietary data analytics platform. Unlike traditional hemodialysis machines, Tablo offers clinical versatility across multiple care settings and a broad range of clinical applications. Studies and surveys have indicated that Tablo can lead to significant operational efficiencies for providers, including reduced costs for dialysis programs, and has demonstrated robust clinical care. Patients using Tablo have reported quality of life benefits compared to other dialysis machines.

Outset Medical, Inc. (NASDAQ:OM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for OM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for OM spans 10-Q, 4, 8-K, 10-K.

Recent high-impact activity:

  • Outset Medical 10-Q: Q3 Revenue $33.6M, Loss Narrows, New FDA Form 483 Disclosed
  • Outset Medical Posts 78-Cent Quarterly Loss Per Share
  • 10% Owner Leonard Braden Michael Buys $870K of Outset Medical Stock
  • Outset Medical Reports Q2 Results, Faces Legal & Regulatory Headwinds, Resets Warrant Price
  • Outset Medical Posts $18M Q2 Loss, Revenue and Outlook in Focus

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$119.48M
Net Income
-$81.65M
Diluted EPS
-$5.37
Op. Cash Flow
-$46.33M
Free Cash Flow
-$47.13M
Gross Profit
$46.75M
Operating Income
-$66.71M
Cash & Equivalents
$35.01M
Total Debt
$96.24M
Debt / Equity
0.76×
Net Margin
-68.3%
Shares Outstanding
18.17M sh
Source: 10-K · filed 2026-02-13 · accession 0001193125-26-051278

Short Interest & Short Volume

8.61 days to cover

FINRA reported short interest of 812,767 shares in OM as of the October 30, 2026 settlement, a 12.8% decrease from the prior period — about 8.6 days to cover at its recent average daily volume. On November 20, 2026, 54.6% of OM volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)812,767 shares as of October 30, 2026
Change vs prior period▼ 12.8%
Days to cover8.61 at avg daily volume of 94,445
Daily short volume (FINRA facilities)54.6% of 28,334 shares on November 20, 2026
5-day average short volume59.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with O →
$2.84 +0.90% today
52-week range · as of 2026-11-04 $2.84 – $12.96
Market cap
$52.97M
Volume
81.3K (0.8× avg)
3-mo avg 96.4K
Live data · 2026-11-22 03:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed OM - Latest Insights

OM
Nov 04, 2026, 5:30 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.43
Real-time Price: $2.84 info
Change: -$1.60 (-36%) info
Market Cap: $52.973M info
OM
Nov 04, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.44
Real-time Price: $2.84 info
Change: -$1.60 (-36%) info
Market Cap: $52.973M info
OM
Oct 05, 2026, 7:24 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $2.84 info
Change: -$1.26 (-31%) info
Market Cap: $52.973M info
OM
Aug 06, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.02
Real-time Price: $2.84 info
Change: -$2.19 (-44%) info
Market Cap: $52.973M info
OM
Aug 06, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $2.84 info
Change: -$2.46 (-47%) info
Market Cap: $52.973M info
OM
Jun 17, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $4.70
Real-time Price: $2.84 info
Change: -$1.86 (-40%) info
Market Cap: $52.973M info
OM
Jun 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.02
Real-time Price: $2.84 info
Change: -$1.18 (-29%) info
Market Cap: $52.973M info
OM
May 29, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.89
Real-time Price: $2.84 info
Change: -$2.05 (-42%) info
Market Cap: $52.973M info
OM
May 07, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.06
Real-time Price: $2.84 info
Change: -$1.22 (-30%) info
Market Cap: $52.973M info
OM
May 07, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.06
Real-time Price: $2.84 info
Change: -$1.22 (-30%) info
Market Cap: $52.973M info
OM
Feb 13, 2026, 4:01 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.39
Real-time Price: $2.84 info
Change: -$0.5546 (-16%) info
Market Cap: $52.973M info
OM
Feb 11, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.54
Real-time Price: $2.84 info
Change: -$1.70 (-38%) info
Market Cap: $52.973M info
OM
Jan 27, 2026, 9:10 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.22
Real-time Price: $2.84 info
Change: -$2.38 (-46%) info
Market Cap: $52.973M info
OM
Jan 12, 2026, 8:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.56
Real-time Price: $2.84 info
Change: -$1.72 (-38%) info
Market Cap: $52.973M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets